Identification of Efflux Pump Mutations in <i>Pseudomonas aeruginosa</i> from Clinical Samples

Identification of Efflux Pump Mutations in <i>Pseudomonas aeruginosa</i> from Clinical Samples

Efflux pumps are a specialized tool of antibiotic resistance used by <i>Pseudomonas aeruginosa</i> to expel antibiotics. The current study was therefore conducted to examine the expression of MexAB-OprM and MexCD-OprJ efflux pump genes. In this study, 200 samples were collected from Khyb...

Bibliografski detalji
Glavni autori:	Sonia Quddus, Zainab Liaqat, Sadiq Azam, Mahboob Ul Haq, Sajjad Ahmad, Metab Alharbi, Ibrar Khan
Format:	Članak
Jezik:	English
Izdano:	MDPI AG 2023-03-01
Serija:	Antibiotics
Teme:	<i>Pseudomonas aeruginosa</i> antibiotic-resistant efflux pump genes nosocomial pathogen antibiotics susceptibility pattern
Online pristup:	https://www.mdpi.com/2079-6382/12/3/486

Slični predmeti

Evaluation of Efflux-Mediated Resistance and Biofilm formation in Virulent <i>Pseudomonas aeruginosa</i> Associated with Healthcare Infections
od: Paul A. Akinduti, i dr.
Izdano: (2023-03-01)

Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa
od: Momen Askoura, i dr.
Izdano: (2011-05-01)

Exposure of <i>Pseudomonas aeruginosa</i> to Cinnamaldehyde Selects Multidrug Resistant Mutants
od: Alexandre Tetard, i dr.
Izdano: (2022-12-01)

Molecular detection of efflux pump genes (MexAB-OprM) in Pseudomonas aeruginosa isolated form Babylon Province
od: Zainab Hafedh Jameel, i dr.
Izdano: (2023-01-01)

Penetration through Outer Membrane and Efflux Potential in <i>Pseudomonas aeruginosa</i> of Bulgecin A as an Adjuvant to β-Lactam Antibiotics
od: Choon Kim, i dr.
Izdano: (2023-02-01)

Molecular determinants of avoidance and inhibition of Pseudomonas aeruginosa MexB efflux pump
od: Silvia Gervasoni, i dr.
Izdano: (2023-08-01)

Multidrug efflux pumps of Pseudomonas aeruginosa show selectivity for their natural substrates
od: Léna Mazza, i dr.
Izdano: (2025-01-01)

Detecting the Efflux Pumps Gene (mexB and oprM ) in MDR Pseudomonas Aeruginosa Isolated from Wound Infection
od: Wael Abbas Hameed AL-Mhesin, i dr.
Izdano: (2024-07-01)

Evaluation of Some Efflux Pump Genes in Pseudomonas aeruginosa and their Relation to Antibiotic Resistance
od: Roaa Abd Al-rahman Abdulla, i dr.
Izdano: (2024-10-01)

Evaluation of Heterocyclic Carboxamides as Potential Efflux Pump Inhibitors in <i>Pseudomonas aeruginosa</i>
od: Yi Yuan, i dr.
Izdano: (2021-12-01)

Evaluation of efflux pump activity and biofilm formation in multidrug resistant clinical isolates of Pseudomonas aeruginosa isolated from a Federal Medical Center in Nigeria
od: Florence Chijindu Ugwuanyi, i dr.
Izdano: (2021-02-01)

Antimicrobial Resistance in <i>Pseudomonas aeruginosa</i> before and during the COVID-19 Pandemic
od: Enrica Serretiello, i dr.
Izdano: (2023-07-01)

Molecular Characterization and Epidemiology of Antibiotic Resistance Genes of β-Lactamase Producing Bacterial Pathogens Causing Septicemia from Tertiary Care Hospitals
od: Mohammad Riaz Khan, i dr.
Izdano: (2023-03-01)

<i>Pseudomonas aeruginosa</i> <i>mexR</i> and <i>mexEF</i> Antibiotic Efflux Pump Variants Exhibit Increased Virulence
od: Mylene Vaillancourt, i dr.
Izdano: (2021-09-01)

Characteristics of Antibiotic Resistance and Tolerance of Environmentally Endemic <i>Pseudomonas aeruginosa</i>
od: Seryoung Kim, i dr.
Izdano: (2022-08-01)

Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> Mutants Overexpressing Efflux Pumps
od: Jorge Olivares Pacheco, i dr.
Izdano: (2017-09-01)

Treatment Heterogeneity in <i>Pseudomonas aeruginosa</i> Pneumonia
od: Aisling R. Caffrey, i dr.
Izdano: (2022-07-01)

Silk-Based Therapeutics Targeting <i>Pseudomonas aeruginosa</i>
od: Tina B. McKay, i dr.
Izdano: (2019-09-01)

Evaluation of a Conformationally Constrained Indole Carboxamide as a Potential Efflux Pump Inhibitor in <i>Pseudomonas</i> <i>aeruginosa</i>
od: Yongzheng Zhang, i dr.
Izdano: (2022-05-01)

Overexpression of the MexXY Multidrug Efflux System Correlates with Deficient Pyoverdine Production in <i>Pseudomonas aeruginosa</i>
od: Kei Ikarashi, i dr.
Izdano: (2021-05-01)

The Impact of the Virulence of <i>Pseudomonas aeruginosa</i> Isolated from Dogs
od: Telma de Sousa, i dr.
Izdano: (2023-05-01)

Mechanisms and regulation of antimicrobial resistance in Pseudomonas aeruginosa
od: Chebotar I.V., i dr.
Izdano: (2017-11-01)

The Impact of an Efflux Pump Inhibitor on the Activity of Free and Liposomal Antibiotics against <i>Pseudomonas aeruginosa</i>
od: Douweh Leyla Gbian, i dr.
Izdano: (2021-04-01)

The History and Applications of Phage Therapy in <i>Pseudomonas aeruginosa</i>
od: Carina Silva, i dr.
Izdano: (2021-12-01)

Role of Relebactam in the Antibiotic Resistance Acquisition in <i>Pseudomonas aeruginosa</i>: In Vitro Study
od: Maria Paz Ventero, i dr.
Izdano: (2023-11-01)

Inference of the phenotypic resistance profile of Pseudomonas aeruginosa through an interpretative reading of the antibiogram in a pediatric hospital. 2006-2014.
od: Juan Jailer Arango, i dr.
Izdano: (2016-07-01)

The antimicrobial peptide Esc(1-21)-1c increases susceptibility of Pseudomonas aeruginosa to conventional antibiotics by decreasing the expression of the MexAB-OprM efflux pump
od: Carolina Canè, i dr.
Izdano: (2023-10-01)

<i>Pseudomonas aeruginosa</i> Infections in Cancer Patients
od: Paulina Paprocka, i dr.
Izdano: (2022-06-01)

A type I-F CRISPRi system unveils the novel role of CzcR in modulating multidrug resistance of Pseudomonas aeruginosa
od: Shuzhen Chen, i dr.
Izdano: (2023-10-01)

Diversity and Distribution of Resistance Markers in <i>Pseudomonas aeruginosa</i> International High-Risk Clones
od: Béla Kocsis, i dr.
Izdano: (2021-02-01)

Determination antimicrobial resistance profile of Pseudomonas aeruginosa strains isolated from hospitalized patients in Taleghani Hospital (Ahvaz, Iran) from 2011-2012
od: Jalal Mardaneh, i dr.
Izdano: (2013-09-01)

Effect of Phthalates and Their Substitutes on the Physiology of <i>Pseudomonas aeruginosa</i>
od: Mélissande Louis, i dr.
Izdano: (2022-09-01)

Resistance in <i>Pseudomonas aeruginosa</i>: A Narrative Review of Antibiogram Interpretation and Emerging Treatments
od: Federico Giovagnorio, i dr.
Izdano: (2023-11-01)

Combined Antibiotic and Photodynamic Therapies in <i>Pseudomonas aeruginosa</i>: From Synergy to Antagonism
od: Amanda C. Zangirolami, i dr.
Izdano: (2024-11-01)

Combinations of Bacteriophage Are Efficacious against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> and Enhance Sensitivity to Carbapenem Antibiotics
od: Christopher J. Kovacs, i dr.
Izdano: (2024-06-01)

Potential Therapeutic Targets for Combination Antibody Therapy against <i>Pseudomonas aeruginosa</i> Infections
od: Luke L. Proctor, i dr.
Izdano: (2021-12-01)

Types and Mechanisms of Efflux Pump Systems and the Potential of Efflux Pump Inhibitors in the Restoration of Antimicrobial Susceptibility, with a Special Reference to <i>Acinetobacter baumannii</i>
od: Kira M. Zack, i dr.
Izdano: (2024-02-01)

Antibiotic Resistance in Pseudomonas Aeruginosa is Associated with Decreased Fitness
od: Zhenzhen Sun, i dr.
Izdano: (2013-03-01)

A Novel and Quantitative Detection Assay (<i>effluxR</i>) for Identifying Efflux-Associated Resistance Genes Using Multiplex Digital PCR in Clinical Isolates of <i>Pseudomonas aeruginosa</i>
od: Nontaporn Rattanachak, i dr.
Izdano: (2023-10-01)

Effects of аntimicrobials on <i>Pseudomonas aeruginosa</i> biofilm formation
od: U. M. Nemchenko, i dr.
Izdano: (2022-09-01)